Cindy’s Gift to End Glioblastoma
Talking Biotech with Dr. Kevin Folta
00:00
GLOSS BLOSS DOMA - What Is the Composition of the Tumor?
The five years survival rate of a patient with g b m diagnosed in the us. Is less than five%. So if you look at that, it's very daunting,. What happens is, when we apply therapes to a cancer, as we were talking about before, we're actually applying an evolutionary selection pressure. It's like d darwinian what we do as we apply these therapes. But all our therapies that we design are based on our knowledge from the primary tumor. We never, we shouldn't ever consider cancer to be a static disease. And gleoblas ma can actually evolve and change more rapidly than other cancers.
Transcript
Play full episode
